Short term methylphenidate treatment does not increase myocardial injury in the ischemic rat heart
Jazyk angličtina Země Česko Médium print-electronic
Typ dokumentu časopisecké články
Grantová podpora
R15 HL145546
NHLBI NIH HHS - United States
PubMed
32469230
PubMed Central
PMC7674266
DOI
10.33549/physiolres.934368
PII: 934368
Knihovny.cz E-zdroje
- MeSH
- infarkt myokardu chemicky indukované patologie MeSH
- ischemická choroba srdeční chemicky indukované patologie MeSH
- kontrakce myokardu účinky léků MeSH
- krysa rodu Rattus MeSH
- methylfenidát škodlivé účinky farmakologie MeSH
- modely nemocí na zvířatech MeSH
- obnova funkce MeSH
- potkani Sprague-Dawley MeSH
- rozvrh dávkování léků MeSH
- stimulanty centrálního nervového systému farmakologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- methylfenidát MeSH
- stimulanty centrálního nervového systému MeSH
Methylphenidate is commonly used for the treatment of attention deficit hyperactivity disorder. The cardiovascular safety of methylphenidate has been a subject of debate with some studies indicating that methylphenidate increases the likelihood of experiencing a myocardial infarction. However, it is unknown whether methylphenidate worsens the extent of injury during an ischemic insult. The purpose of this study was to determine whether short term exposure to methylphenidate increases the extent of myocardial injury during an ischemic insult. Male and female rats received methylphenidate (5 mg/kg/day) or saline for 10 days by oral gavage. Hearts were subjected to 20 min of ischemia and 2 h of reperfusion on a Langendorff isolated heart apparatus on day 11. Cardiac contractile function was monitored via an intraventricular balloon and myocardial injury was assessed by triphenyltetrazolium chloride staining. Methylphenidate significantly increased locomotor activity in male and female rats, confirming absorption of this psychostimulant into the central nervous system. Male hearts had significantly larger infarcts than female hearts, but methylphenidate had no impact on infarct size or postischemic recovery of contractile function in hearts of either sex. These data indicate that methylphenidate does not increase the extent of injury induced by an ischemic insult.
Zobrazit více v PubMed
ANTEL J, ALBAYRAK O, HEUSCH G, BANASCHEWSKI T, HEBEBRAND J. Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)? Eur Arch Psychiatry Clin Neurosci. 2015;265:233–247. doi: 10.1007/s00406-014-0522-8. PubMed DOI
BROWN DA, LYNCH JM, ARMSTRONG CJ, CARUSO NM, EHLERS LB, JOHNSON MS, MOORE RL. Susceptibility of the heart to ischaemia-reperfusion injury and exercise-induced cardioprotection are sex-dependent in the rat. J Physiol. 2005;564:619–630. doi: 10.1113/jphysiol.2004.081323. PubMed DOI PMC
DONG N, ZHU J, HAN W, WANG S, YAN Z, MA D, GOH ELK, CHEN T. Maternal methamphetamine exposure causes cognitive impairment and alteration of neurodevelopment-related genes in adult offspring mice. Neuropharmacology. 2018;140:25–34. doi: 10.1016/j.neuropharm.2018.07.024. PubMed DOI
GERASIMOV MR, FRANCESCHI M, VOLKOW ND, GIFFORD A, GATLEY SJ, MARSTELLER D, MOLINA PE, DEWEY SL. Comparison between intraperitoneal and oral methylphenidate administration: A microdialysis and locomotor activity study. J Pharmacol Exp Ther. 2000;295:51–57. PubMed
HAN DD, GU HH. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol. 2006;6:6. PubMed PMC
HOLUBOVA A, SEVCIKOVA M, MACUCHOVA E, HREBICKOVA I, POMETLOVA M, SLAMBEROVA R. Effects of perinatal stress and drug abuse on maternal behavior and sensorimotor development of affected progeny. Physiol Res. 2017;66(Suppl 4):S481–S491. doi: 10.33549/physiolres.933800. PubMed DOI
HREBICKOVA I, SEVCIKOVA M, NOHEJLOVA K, SLAMBEROVA R. Does effect from developmental methamphetamine exposure on spatial learning and memory depend on stage of neuroontogeny? Physiol Res. 2016;65(Suppl 5):S577–S589. doi: 10.33549/physiolres.933534. PubMed DOI
JOHNSON MS, MOORE RL, BROWN DA. Sex differences in myocardial infarct size are abolished by sarcolemmal KATP channel blockade in rat. Am J Physiol Heart Circ Physiol. 2006;290:H2644–H2647. doi: 10.1152/ajpheart.01291.2005. PubMed DOI
LAVRETSKY H, KIM MD, KUMAR A, REYNOLDS CF., 3RD Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial. J Clin Psychiatry. 2003;64:1410–1414. doi: 10.4088/jcp.v64n1202. PubMed DOI
LAVRETSKY H, REINLIEB M, St CYR N, SIDDARTH P, ERCOLI LM, SENTURK D. Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry. 2015;172:561–569. doi: 10.1176/appi.ajp.2014.14070889. PubMed DOI PMC
LEUNG KP, QU YH, QIAO DF, XIE WB, LI DR, XU JT, WANG HJ, YUE X. Critical role of insulinlike growth factor binding protein5 in methamphetamineinduced apoptosis in cardiomyocytes. Mol Med Rep. 2014;10:2306–2312. doi: 10.3892/mmr.2014.2572. PubMed DOI PMC
LIU H, FENG W, ZHANG D. Association of ADHD medications with the risk of cardiovascular diseases: a meta-analysis. Eur Child Adolesc Psychiatry. 2019;28:1283–1293. doi: 10.1007/s00787-018-1217-x. PubMed DOI
LUETHI D, KAESER PJ, BRANDT SD, KRAHENBUHL S, HOENER MC, LIECHTI ME. Pharmacological profile of methylphenidate-based designer drugs. Neuropharmacology. 2018;134:133–140. doi: 10.1016/j.neuropharm.2017.08.020. PubMed DOI
MA Y, CHENG WT, WU S, WONG TM. Oestrogen confers cardioprotection by suppressing Ca2+/calmodulin-dependent protein kinase II. Br J Pharmacol. 2009;157:705–715. doi: 10.1111/j.1476-5381.2009.00212.x. PubMed DOI PMC
MAENO Y, IWASA M, INOUE H, KOYAMA H, MATOBA R, NAGAO M. Direct effects of methamphetamine on hypertrophy and microtubules in cultured adult rat ventricular myocytes. Forensic Sci Int. 2000;113:239–243. doi: 10.1016/s0379-0738(00)00216-4. PubMed DOI
MILEROVA M, DRAHOTA Z, CHYTILOVA A, TAUCHMANNOVA K, HOUSTEK J, OSTADAL B. Sex difference in the sensitivity of cardiac mitochondrial permeability transition pore to calcium load. Mol Cell Biochem. 2016;412:147–154. doi: 10.1007/s11010-015-2619-4. PubMed DOI
MONTAGNINI BG, SILVA LS, Dos SANTOS AH, ANSELMO-FRANCI JA, FERNANDES GS, MESQUITA SDEF, GERARDIN DC. Effects of repeated administration of methylphenidate on reproductive parameters in male rats. Physiol Behav. 2014;133:122–129. doi: 10.1016/j.physbeh.2014.05.016. PubMed DOI
MUNK K, GORMSEN L, KIM WY, ANDERSEN NH. Cardiac arrest following a myocardial infarction in a child treated with methylphenidate. Case Rep Pediatr. 2015;2015:905097. doi: 10.1155/2015/905097. PubMed DOI PMC
PADALA PR, PADALA KP, LENSING SY, RAMIREZ D, MONGA V, BOPP MM, ROBERSON PK, DENNIS RA, PETTY F, SULLIVAN DH, BURKE WJ. Methylphenidate for apathy in community-dwelling older veterans with mild Alzheimer's disease: A double-blind, randomized, placebo-controlled trial. Am J Psychiatry. 2018;175:159–168. doi: 10.1176/appi.ajp.2017.17030316. PubMed DOI
PATEL K, ABDOOL PS, RAJJI TK, MULSANT BH. Pharmacotherapy of major depression in late life: what is the role of new agents? Expert Opin Pharmacother. 2017;18:599–609. doi: 10.1080/14656566.2017.1308484. PubMed DOI
PAULY V, FRAUGER E, LEPELLEY M, MALLARET M, BOUCHERIE Q, MICALLEF J. Patterns and profiles of methylphenidate use both in children and adults. Br J Clin Pharmacol. 2018;84:1215–1227. doi: 10.1111/bcp.13544. PubMed DOI PMC
PIPER BJ, OGDEN CL, SIMOYAN OM, CHUNG DY, CAGGIANO JF, NICHOLS SD, McCALL KL. Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016. PLoS One. 2018;13:e0206100. doi: 10.1371/journal.pone.0206100. PubMed DOI PMC
RORABAUGH B, SEELEY S, EVANS M, MARENGO C, D'SOUZA M. Differential behavioral effects of nicotine in adult male and female rats with a history of prenatal methamphetamine exposure. Neurosci Lett. 2017a;651:116–122. doi: 10.1016/j.neulet.2017.05.002. PubMed DOI
RORABAUGH BR, CHAKRAVARTI B, MABE NW, SEELEY SL, BUI AD, YANG J, WATTS SW, NEUBIG RR, FISHER RA. Regulator of G protein signaling 6 protects the heart from ischemic injury. J Pharmacol Exp Ther. 2017b;360:409–416. doi: 10.1124/jpet.116.238345. PubMed DOI PMC
RORABAUGH BR, SEELEY SL, BUI AD, SPRAGUE L, D'SOUZA MS. Prenatal methamphetamine differentially alters myocardial sensitivity to ischemic injury in male and female adult hearts. Am J Physiol Heart Circ Physiol. 2016;310:H516–H523. doi: 10.1152/ajpheart.00642.2015. PubMed DOI
RORABAUGH BR, SEELEY SL, STOOPS TS, D'SOUZA MS. Repeated exposure to methamphetamine induces sex-dependent hypersensitivity to ischemic injury in the adult rat heart. PLoS One. 2017c;12:e0179129. doi: 10.1371/journal.pone.0179129. PubMed DOI PMC
ROSENBERG PB, LANCTOT KL, DRYE LT, HERRMANN N, SCHERER RW, BACHMAN DL, MINTZER JE, ADMET INVESTIGATORS. Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial. J Clin Psychiatry. 2013;74:810–816. doi: 10.4088/jcp.12m08099. PubMed DOI PMC
SCHULTZ JE, HSU AK, BARBIERI JT, LI PL, GROSS GJ. Pertussis toxin abolishes the cardioprotective effect of ischemic preconditioning in intact rat heart. Am J Physiol. 1998;275:H495–H500. doi: 10.1152/ajpheart.1998.275.2.h495. PubMed DOI
SHAO Q, FALLICA J, CASIN KM, MURPHY E, STEENBERGEN C, KOHR MJ. Characterization of the sex-dependent myocardial S-nitrosothiol proteome. Am J Physiol Heart Circ Physiol. 2016;310:H505–H515. doi: 10.1152/ajpheart.00681.2015. PubMed DOI PMC
SHIN JY, ROUGHEAD EE, PARK BJ, PRATT NL. Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study. BMJ. 2016;353:i2550. doi: 10.1136/bmj.i2550. PubMed DOI PMC
SLAMBEROVA R. Review of long-term consequences of maternal methamphetamine exposure. Physiol Res. 2019;68(Suppl 3):S219–S231. doi: 10.33549/physiolres.934360. PubMed DOI
SUGIMOTO K, OKAMURA K, TANAKA H, TAKASHIMA S, OCHI H, YAMAMOTO T, MATOBA R. Methamphetamine directly accelerates beating rate in cardiomyocytes by increasing Ca(2+) entry via L-type Ca(2+) channel. Biochem Biophys Res Commun. 2009;390:1214–1220. doi: 10.1016/j.bbrc.2009.10.124. PubMed DOI
THOMPSON J, THOMPSON JR. Acute myocardial infarction related to methylphenidate for adult attention deficit disorder. J Emerg Med. 2010;38:18–21. doi: 10.1016/j.jemermed.2007.06.021. PubMed DOI
WANG Y, WANG Q, ZHAO Y, GONG D, WANG D, LI C, ZHAO H. Protective effects of estrogen against reperfusion arrhythmias following severe myocardial ischemia in rats. Circ J. 2010;74:634–643. doi: 10.1253/circj.cj-09-0223. PubMed DOI
WONG YN, KING SP, LAUGHTON WB, McCORMICK GC, GREBOW PE. Single-dose pharmacokinetics of modafinil and methylphenidate given alone or in combination in healthy male volunteers. J Clin Pharmacol. 1998;38:276–282. doi: 10.1002/j.1552-4604.1998.tb04425.x. PubMed DOI
ZULOAGA DG, WANG J, WEBER S, MARK GP, MURPHY SJ, RABER J. Chronic methamphetamine exposure prior to middle cerebral artery occlusion increases infarct volume and worsens cognitive injury in Male mice. Metab Brain Dis. 2016;31:975–981. doi: 10.1007/s11011-016-9808-z. PubMed DOI PMC